Lupin’s arm gets nod to market generic version of Spiriva

27 May 2023 Evaluate

Lupin’s Canada subsidiary -- Lupin Pharma Canada, has received approval from Health Canada to market a generic version of Spiriva (tiotropium bromide inhalation powder) for the treatment of chronic obstructive pulmonary disease (COPD), in Canada.

Tiotropium Bromide Inhalation Powder is indicated for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema. It is also used to relieve wheezing, shortness of breath, coughing, and chest tightness in patients with COPD. Tiotropium Bromide Inhalation Powder (RLD Spiriva) had estimated annual sales of $42 million in Canada.  

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2170.35 -7.85 (-0.36%)
20-Jan-2026 14:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.65
Dr. Reddys Lab 1175.85
Cipla 1380.80
Zydus Lifesciences 875.95
Lupin 2170.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×